Advertisement

Topics

FUJIFILM Diosynth Biotechnologies Announces New Service Offering to Support Development and cGMP Monoclonal Antibody Production

09:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
FUJIFILM Diosynth Biotechnologies, a leading global biologics Contract Development and Manufacturing Organization (CDMO), has announced the expansion of its Monoclonal Antibody development and manufacturing services with ...

Other Sources for this Article

FUJIFILM Diosynth Biotechnologies
Liza M. Rivera, 919-337-4425
liza.rivera@fujifilm.com
or
Fujifilm
Lauren Geloso, 914-798-8303
lgeloso@fujifilm.com

NEXT ARTICLE

More From BioPortfolio on "FUJIFILM Diosynth Biotechnologies Announces New Service Offering to Support Development and cGMP Monoclonal Antibody Production"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...